Diamond Therapeutics
Grant McCutcheon began their work experience as a Lawyer at Fasken Campbell Godfrey from 1987 to 1992. Grant then moved on to become a Partner, Director, and Corporate Secretary at Lawrence and Company from 1995 to 2009. Following that, they joined Lawrence Asset Management Inc. as Vice President, Director, and Corporate Secretary from 2007 to 2009. In 2010, Grant served as CEO and Director at both Look Communications and Unique Broadband Systems until 2013 and 2016, respectively. From 2017 onward, they became a Founding Partner at Cuspis Capital. Currently, Grant is the Chief Financial Officer at Diamond Therapeutics as of 2021.
Grant McCutcheon received a Bachelor's degree in Pre-Law Studies from Western University in 1985. From 1985 to 1987, they pursued a Bachelor of Laws (LLB) from the same institution. In 1989, Grant attended the Ontario Bar Admission. In 1992, they enrolled at the Thunderbird School of Global Management and obtained a Master of Business Administration (MBA) with a focus on Business Administration, Management, and Operations in 1993.
This person is not in any teams
This person is not in any offices
Diamond Therapeutics
Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort — maximizingthe positive impact better drugs can have on the global mental health crisis.